MLR blast cells generated in mutant‐standard strain combinations bind H‐2K and H‐2D antigens

Roy W. Geib, Jan Klein

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Strains CBA (M523) ( = M523) and CBA differ by a mutation which has been mapped genetically into the K region of the H‐2 complex. Similarly, strains B 10.D2 (M504) ( = MS04) and B10.D2 differ in a mutation which occurred in the D region. The data presented in this study show that mixed lymphocyte culture in M523 anti‐ CBA and M504 anti‐B 10.D2 strain combinations leads to the release of membrane fragments from the stimulating cells and binding of these fragments by blast cells. The fragments always carry H‐2K (in the M523 anti‐CBA combination) or H‐2D (in the M504 anti‐B 10.D2 combination) antigens present in the stimulating and absent in the responding cells (antigens H‐2.60 and H‐2.40, respectively). Although Ia antigens may occasionally be present on the CBA membrane fragments, these antigens do not participate in the M523 anti‐CBA MLR stimulation. The data thus demonstrate that serologically detectable H‐2K and H‐2D antigens can induce a MLR and that a mutation can change properties of H‐2K or H‐2D molecules so that the alteration is detectable by both serological means and lymphocyte activation assays.

Original languageEnglish (US)
Pages (from-to)135-139
Number of pages5
JournalEuropean Journal of Immunology
Volume9
Issue number2
DOIs
StatePublished - Feb 1979

Fingerprint

Antigens
Mutation
Membranes
Histocompatibility Antigens Class II
Lymphocyte Activation
Lymphocytes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

MLR blast cells generated in mutant‐standard strain combinations bind H‐2K and H‐2D antigens. / Geib, Roy W.; Klein, Jan.

In: European Journal of Immunology, Vol. 9, No. 2, 02.1979, p. 135-139.

Research output: Contribution to journalArticle

@article{469ef7a6c74840e89c25a40736643d2b,
title = "MLR blast cells generated in mutant‐standard strain combinations bind H‐2K and H‐2D antigens",
abstract = "Strains CBA (M523) ( = M523) and CBA differ by a mutation which has been mapped genetically into the K region of the H‐2 complex. Similarly, strains B 10.D2 (M504) ( = MS04) and B10.D2 differ in a mutation which occurred in the D region. The data presented in this study show that mixed lymphocyte culture in M523 anti‐ CBA and M504 anti‐B 10.D2 strain combinations leads to the release of membrane fragments from the stimulating cells and binding of these fragments by blast cells. The fragments always carry H‐2K (in the M523 anti‐CBA combination) or H‐2D (in the M504 anti‐B 10.D2 combination) antigens present in the stimulating and absent in the responding cells (antigens H‐2.60 and H‐2.40, respectively). Although Ia antigens may occasionally be present on the CBA membrane fragments, these antigens do not participate in the M523 anti‐CBA MLR stimulation. The data thus demonstrate that serologically detectable H‐2K and H‐2D antigens can induce a MLR and that a mutation can change properties of H‐2K or H‐2D molecules so that the alteration is detectable by both serological means and lymphocyte activation assays.",
author = "Geib, {Roy W.} and Jan Klein",
year = "1979",
month = "2",
doi = "10.1002/eji.1830090208",
language = "English (US)",
volume = "9",
pages = "135--139",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag",
number = "2",

}

TY - JOUR

T1 - MLR blast cells generated in mutant‐standard strain combinations bind H‐2K and H‐2D antigens

AU - Geib, Roy W.

AU - Klein, Jan

PY - 1979/2

Y1 - 1979/2

N2 - Strains CBA (M523) ( = M523) and CBA differ by a mutation which has been mapped genetically into the K region of the H‐2 complex. Similarly, strains B 10.D2 (M504) ( = MS04) and B10.D2 differ in a mutation which occurred in the D region. The data presented in this study show that mixed lymphocyte culture in M523 anti‐ CBA and M504 anti‐B 10.D2 strain combinations leads to the release of membrane fragments from the stimulating cells and binding of these fragments by blast cells. The fragments always carry H‐2K (in the M523 anti‐CBA combination) or H‐2D (in the M504 anti‐B 10.D2 combination) antigens present in the stimulating and absent in the responding cells (antigens H‐2.60 and H‐2.40, respectively). Although Ia antigens may occasionally be present on the CBA membrane fragments, these antigens do not participate in the M523 anti‐CBA MLR stimulation. The data thus demonstrate that serologically detectable H‐2K and H‐2D antigens can induce a MLR and that a mutation can change properties of H‐2K or H‐2D molecules so that the alteration is detectable by both serological means and lymphocyte activation assays.

AB - Strains CBA (M523) ( = M523) and CBA differ by a mutation which has been mapped genetically into the K region of the H‐2 complex. Similarly, strains B 10.D2 (M504) ( = MS04) and B10.D2 differ in a mutation which occurred in the D region. The data presented in this study show that mixed lymphocyte culture in M523 anti‐ CBA and M504 anti‐B 10.D2 strain combinations leads to the release of membrane fragments from the stimulating cells and binding of these fragments by blast cells. The fragments always carry H‐2K (in the M523 anti‐CBA combination) or H‐2D (in the M504 anti‐B 10.D2 combination) antigens present in the stimulating and absent in the responding cells (antigens H‐2.60 and H‐2.40, respectively). Although Ia antigens may occasionally be present on the CBA membrane fragments, these antigens do not participate in the M523 anti‐CBA MLR stimulation. The data thus demonstrate that serologically detectable H‐2K and H‐2D antigens can induce a MLR and that a mutation can change properties of H‐2K or H‐2D molecules so that the alteration is detectable by both serological means and lymphocyte activation assays.

UR - http://www.scopus.com/inward/record.url?scp=0018774619&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018774619&partnerID=8YFLogxK

U2 - 10.1002/eji.1830090208

DO - 10.1002/eji.1830090208

M3 - Article

C2 - 155530

AN - SCOPUS:0018774619

VL - 9

SP - 135

EP - 139

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 2

ER -